Oestrogen receptor (ER) status was positive in 125 (63%) and negative in 74 (37%) patients diagnosed with breast cancer. By comparing the cohorts of ER negative to ER positive patients, one can accurately identify which clinical variables bear clinical significance in this population and are affected by ER status, as well as impact patient outcome.